rs117736426

Variant summary

Our verdict is Benign. The variant received -10 ACMG points: 2P and 12B. PM2BP4_StrongBP6_Very_Strong

The NM_002458.3(MUC5B):​c.7829C>G​(p.Thr2610Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0281 in 1,610,006 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.019 ( 0 hom., cov: 31)
Exomes 𝑓: 0.029 ( 1 hom. )

Consequence

MUC5B
NM_002458.3 missense

Scores

1
16

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: 0.172

Publications

5 publications found
Variant links:
Genes affected
MUC5B (HGNC:7516): (mucin 5B, oligomeric mucus/gel-forming) This gene encodes a member of the mucin family of proteins, which are highly glycosylated macromolecular components of mucus secretions. This family member is the major gel-forming mucin in mucus. It is a major contributor to the lubricating and viscoelastic properties of whole saliva, normal lung mucus and cervical mucus. This gene has been found to be up-regulated in some human diseases, including sinus mucosa of chronic rhinosinusitis (CRS), CRS with nasal polyposis, chronic obstructive pulmonary disease (COPD) and H. pylori-associated gastric disease, and it may be involved in the pathogenesis of these diseases. [provided by RefSeq, Jul 2010]
MUC5B-AS1 (HGNC:53936): (MUC5B antisense RNA 1)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -10 ACMG points.

PM2
Variant has high frequency in the NFE (0.0313) population. However there is too low homozygotes in high coverage region: (expected more than 317, got 1).
BP4
Computational evidence support a benign effect (MetaRNN=0.00386253).
BP6
Variant 11-1244709-C-G is Benign according to our data. Variant chr11-1244709-C-G is described in ClinVar as Benign. ClinVar VariationId is 403144.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MUC5BNM_002458.3 linkc.7829C>G p.Thr2610Ser missense_variant Exon 31 of 49 ENST00000529681.5 NP_002449.2 Q9HC84
MUC5B-AS1NR_157183.1 linkn.57-2071G>C intron_variant Intron 1 of 1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MUC5BENST00000529681.5 linkc.7829C>G p.Thr2610Ser missense_variant Exon 31 of 49 5 NM_002458.3 ENSP00000436812.1 Q9HC84
MUC5B-AS1ENST00000532061.2 linkn.57-2071G>C intron_variant Intron 1 of 1 5

Frequencies

GnomAD3 genomes
AF:
0.0188
AC:
2831
AN:
150770
Hom.:
0
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.0112
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00539
Gnomad ASJ
AF:
0.0215
Gnomad EAS
AF:
0.000193
Gnomad SAS
AF:
0.00562
Gnomad FIN
AF:
0.0492
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0244
Gnomad OTH
AF:
0.0160
GnomAD2 exomes
AF:
0.0229
AC:
5665
AN:
247676
AF XY:
0.0228
show subpopulations
Gnomad AFR exome
AF:
0.0133
Gnomad AMR exome
AF:
0.00349
Gnomad ASJ exome
AF:
0.0244
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0697
Gnomad NFE exome
AF:
0.0290
Gnomad OTH exome
AF:
0.0211
GnomAD4 exome
AF:
0.0290
AC:
42363
AN:
1459118
Hom.:
1
Cov.:
151
AF XY:
0.0284
AC XY:
20612
AN XY:
725838
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.0116
AC:
389
AN:
33428
American (AMR)
AF:
0.00553
AC:
247
AN:
44670
Ashkenazi Jewish (ASJ)
AF:
0.0280
AC:
730
AN:
26070
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39698
South Asian (SAS)
AF:
0.00882
AC:
760
AN:
86138
European-Finnish (FIN)
AF:
0.0673
AC:
3573
AN:
53062
Middle Eastern (MID)
AF:
0.00452
AC:
26
AN:
5746
European-Non Finnish (NFE)
AF:
0.0316
AC:
35053
AN:
1110054
Other (OTH)
AF:
0.0263
AC:
1585
AN:
60252
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.343
Heterozygous variant carriers
0
3691
7382
11073
14764
18455
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
1326
2652
3978
5304
6630
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0188
AC:
2830
AN:
150888
Hom.:
0
Cov.:
31
AF XY:
0.0193
AC XY:
1422
AN XY:
73782
show subpopulations
⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.0112
AC:
462
AN:
41350
American (AMR)
AF:
0.00538
AC:
82
AN:
15238
Ashkenazi Jewish (ASJ)
AF:
0.0215
AC:
74
AN:
3434
East Asian (EAS)
AF:
0.000194
AC:
1
AN:
5166
South Asian (SAS)
AF:
0.00542
AC:
26
AN:
4798
European-Finnish (FIN)
AF:
0.0492
AC:
508
AN:
10334
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
292
European-Non Finnish (NFE)
AF:
0.0244
AC:
1644
AN:
67278
Other (OTH)
AF:
0.0158
AC:
33
AN:
2086
⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5. (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.351
Heterozygous variant carriers
0
122
244
366
488
610
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
34
68
102
136
170
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0151
Hom.:
0
ESP6500AA
AF:
0.0160
AC:
67
ESP6500EA
AF:
0.0325
AC:
273
ExAC
AF:
0.0273
AC:
3302

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:1
Mar 28, 2016
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.14
BayesDel_addAF
Benign
-0.66
T
BayesDel_noAF
Benign
-0.70
CADD
Benign
6.0
DANN
Benign
0.63
DEOGEN2
Benign
0.025
T
Eigen
Benign
-1.2
Eigen_PC
Benign
-1.3
FATHMM_MKL
Benign
0.012
N
LIST_S2
Benign
0.15
T
MetaRNN
Benign
0.0039
T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
0.55
N
PhyloP100
0.17
PrimateAI
Benign
0.24
T
PROVEAN
Benign
-0.72
N
REVEL
Benign
0.014
Sift
Pathogenic
0.0
D
Vest4
0.050
ClinPred
0.011
T
GERP RS
0.40
Varity_R
0.10
gMVP
0.14
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs117736426; hg19: chr11-1265939; API